The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 767-771

  Stýblo, Miroslav ^a   Drobná, Zuzana ^a   Jaspers, Ilona ^a   Lin, Shan ^a   Thomas, David J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

AP 1; Arsenic; Cancer; Inhibition; Methylated arsenic; Methylation; Methyltransferase; Toxicity; Transcription control

Indexed keywords

ARSENIC;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CHEMICAL COMPOSITION; CHEMICAL REACTION; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DNA DAMAGE; ENZYME INHIBITION; ENZYME MECHANISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MEDICAL RESEARCH; METHYLATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; MAMMALIA;

EID: 0036803041     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.110-1241242     Document Type: Article

References (46)

1. Cullen WR, McBride BC, Reglinski J. The reaction of methylarsenicals with thiols: some biological implications. J Inorg Biochem 21:179-194 (1984).
2. Scott N, Hatlelid KM, MacKenzie NE, Carter DE. Reaction of arsenic(III) and arsenic(V) species with glutathione. Chem Res Toxicol 6:102-106 (1993).
3. Delnomdedieu M, Basti MM, Otvos JD, Thomas DJ. Reduction and binding of arsenate and dimethylarsenate by glutathione: a multinuclear magnetic resonance study. Chem Biol Interact 90:139-155 (1994).
4. Zakharyan RA, Aposhian HV. Enzymatic reduction of arsenic compounds in mammlian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem Res Toxico 12:1278-1283 (1999).
5. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, et al. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13:693-697 (2000).
6. Zakharyan R, Wu Y, Bogdan GM, Aposhian HV. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase from rabbit liver. Chem Res Toxicol 8:1029-1038 (1995).
7. Lin S, Shi Q, Nix B, Styblo M, Beck M, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ. A novel S-adonosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795-10803 (2002).
8. Thomas DJ, Styblo M, Shan L. Cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176:127-144 (2001).
9. Styblo M, Serves SV, Cullen WR, Thomas DJ. Comparative inhibition of yeast glutatione reductase by arsenicals and arsenothiols. Chem Res Toxicol 10:27-33 (1997).
10. Petrick JS, Jagadish B, Mash EA, Aposhian HV. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 14:651-656 (2001).
11. Lin S, Cullen WR, Thomas DJ. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem Res Toxicol 12:924-930 (1999).
12. Styblo M, Vega L, Germolec DR, Luster MI, Del Razo LM, Wang C, Cullen WR, Thomas DJ. Metabolism and toxicity of arsenicals in cultured cells. In: Arsenic Exposure and Health Effects (Chappell WR, Abernathy CO, Calderon RL, eds). Oxford:Elsevier, 1999;311-323.
13. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in human cells. Arch Toxicol 74:289-299 (2000).
14. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Aposhian HV. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163:203-207 (2000).
15. Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol Appl Pharmacol 172:225-232 (2001).
16. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ, Kligerman AD. Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 14:355-361 (2001).
17. Le XC, Lu X, Ma M, Cullen WR, Aposhian HV, Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal Chem 72:5172-5177 (2000).
18. Del Razo LM, Styblo M, Cullen WR, Thomas DJ. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 174:282-293 (2001).
19. Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108:1015-1018 (2000).
20. Mandal BK, Ogra Y, Suzuki KT. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14:371-378 (2001).
21. Drobná Z, Styblo M. Unpublished data (2001).
22. Styblo M, Chen G-Q, Waxman S. Unpublished data (2001).
23. Styblo M, Rossman TG. Unpublished data (2000).
24. Styblo M, Blatt J. Unpublished data (2001).
25. Walton FS, Styblo M, Patel Y. Unpublished data (2001).
26. Walton FS, Styblo M. Unpublished data (2000).
27. Styblo M, Mass MJ, Kligerman AD. Unpublished data (2001).
28. Kitchin K. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172:249-261 (2001).
29. Simeonova PP, Luster MI. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol 19:281-286 (2000).
30. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE Arsenic induces oxidant stress and NF-κB activation in cultured aortic endothelial cells. Free Radic Biol Med 21:73-790 (1996).
31. Salazar AM, Ostrowsky-Wegman P, Menedez D, Miranda E, Garcia-Carranca A, Rojas E. Induction of p53 protein expression by sodium arsenite. Mutat Res 381:259-265 (1997).
32. Burleson FG, Simeonova PP, Germolec DR, Luster MI. Dermatotoxic chemicl stimulae of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes. Res Commun Mol Pathol Pharmacol 93:131-148 (1996).
33. Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, Karin M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15:6269-6279 (1196).
34. Simeonova PP, Wang S, Toriumi W, Kommineni C, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, et al. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with AP-1 transactivation. Cancer Res 60: 3445-3453 (2000).
35. Drobná Z, Jaspers I, Thomas DJ, Styblo M (submitted). Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals. FASEB J (in press).
36. Bates MN, Smith AH, Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135:462-676 (1992).
37. Morris RD. Drinking water and cancer. Environ Health Perspect 103(suppl 8):225-231 (1995).
38. Guo HR, Chiang HS, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8:545-550 (1997).
39. Radabaugh TR, Aposhian HV. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxicol 13:26-30 (2000).
40. Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, Aposhian HV. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 14:1051-1057 (2001).
41. Buchet JP, Lauwerys R. Study of inorganic arsenic methylation by rat in vitro: revelance for the interpretation of observations in man. Arch Toxicol 57:125-129 (1985).
42. Styblo M, Delnomdedieu M, Thomas DJ. Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem-Biol Interact 99:147-164 (1996).
43. Lin S, Thomas DJ. Unpublished data (2001).
44. Holmgren A. Thioredoxin structure and mechanism: conformational changes and oxidation of the active-site sulfhydryls to a disulfide. Structure 3:239-243 (1995).
45. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264:13963-13966 (1989).
46. Lin S, Del Razo LM, Styblo M, Wang C, Cullen WR, Thomas DJ. Arsenicals inhibit thioredoxin reductasse in cultured rat hepatocytes. Chem Res Toxicol 14:305-311 (2001).